A vaccine composition and a method for inducing a systemic immune response and a mucosal immune response, where the vaccine composition comprises an antigen and hepatitis B virus-like particles as an adjuvant. The vaccine composition is applicable on a mucosal surface of a test subject receiving a medicament and is efficacious in initiating a protective immune response against an infection.